Founded in 2015, Zetagen is a private, clinical-stage, biopharmaceutical company dedicated to driving breakthrough innovation in the treatment of metastatic bone cancers and osteologic interventions. Our multi-patented, ZetaMet™ technology is a first-of-its kind molecular pathway designed to suspend cancer, inhibit pain, and regenerate bone. Zetagen exclusively-licensed the platform technology from the State University of New York in 2016.
This novel therapy, a drug-eluting implant technology, has successfully passed its preclinical trials and is being prepared for its first human clinical trial in Q4 2021. In addition to ZetaMet™, the Company’s pipeline includes other oncologic treatments for Skeletal Related Events (SREs), i.e., ZetaMet Flowable™ and ancillary osteologic treatments including, ZetaFuse™, ZetaSet™, ZetaDent™ and ZetaBase™. The Company is supported through Series A funding, private and angel investors, and Phase I and Phase II NIH research grants.
Company Details
- Employees
- 10
- Founded
- -
- Address
- 841 E Fayette St, Syracuse,new York,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- zetagen.com
- HQ
- Syracuse, New York
Zetagen Therapeutics Questions
Zetagen Therapeutics's website is zetagen.com
Zetagen Therapeutics's LinkedIn profile is https://www.linkedin.com/company/zetagen-therapeutics
Zetagen Therapeutics has
10 employees.
View email and phone details for 10
employees at Zetagen Therapeutics.
Zetagen Therapeutics's industry is
Pharmaceutical Manufacturing
Zetagen Therapeutics's top competitors are
Triton Bio,
Cormac Life Sciences,
Insurgical Powered Instruments,
Hoth Therapeutics, Inc,
Medtech Innovator,
Genscript,
Sonnet Biotherapeutics,
Zetagene,
Tetmedical, Inc.,
L2 Bio.
Zetagen Therapeutics's categories are Pharmaceutical Manufacturing
Zetagen Therapeutics's founding year is 2015
